Frequently asked questions about IMCIVREE


Actor portrayals
IMCIVREE is a treatment for obesity due to POMC, PCSK1, or LEPR deficiency confirmed by genetic testing. The test must show that the change, or variant, is considered pathogenic, likely pathogenic, or uncertain. IMCIVREE should not be used by someone with obesity due to suspected POMC, PCSK1, or LEPR deficiency not confirmed by genetic testing (benign or likely benign result) or someone with another type of obesity not related to POMC, PCSK1, or LEPR deficiency, including obesity associated with other genetic conditions and general obesity. It’s always best to talk to your healthcare provider to determine if a treatment is right for you.
Each individual is different and results can vary from person to person. Please visit here to see more about how IMCIVREE impacted weight.
Do not use IMCIVREE if you have had a serious allergic reaction to it or any of its ingredients. Serious allergic reactions, including anaphylaxis, can happen.
The most common side effects of IMCIVREE include darkening of the skin, injection site reactions, nausea, headache, diarrhea, stomach pain, vomiting, depression, and an erection that happens without any sexual activity in males.
These are not all the possible side effects of IMCIVREE. Please see full Prescribing Information, including Patient Information. You are encouraged to report negative side effects of prescription drugs to FDA. Visit www.fda.gov/medwatch or call FDA at 1-800-FDA-1088.
It's best to reach out to your current healthcare provider for more information. In clinical trials, most nausea and vomiting events were mild, and none were severe. Nausea and vomiting primarily were reported within the first month of treatment and typically went away after a few days.
IMCIVREE must be taken daily to be effective. In clinical trials for people 6 years and older, when IMCIVREE was stopped, individuals experienced weight gain. When the withdrawal period ended and treatment was restarted, weight loss continued. Speak to your healthcare provider to determine the best treatment plan for you.
Insurance coverage varies from plan to plan. We invite you to contact Rhythm InTune at 1-855-206-0815 or patientsupport@rhythmtx.com. Our team members would be happy to help you look into options and plan next steps.
We invite you to contact Rhythm InTune at 1-855-206-0815 or patientsupport@rhythmtx.com to learn more about financial support options that may be available to eligible patients.
The first place to turn is always your healthcare provider, who can determine the right treatment for you. Rhythm InTune may also be able to help with questions about taking IMCIVREE, insurance coverage, financial support programs, and ongoing support. Contact Rhythm InTune at 1-855-206-0815 or patientsupport@rhythmtx.com.
Have more questions?
Your Rhythm InTune Patient Education Manager (PEM)* can provide education about POMC, PCSK1, or LEPR deficiency, wellness education, and resources tailored to your needs.
*Patient Education Managers are employees of Rhythm Pharmaceuticals and do not provide medical care or advice. We encourage you to always speak to your healthcare providers regarding your medical care.